Jessica Jensen
-
- Radiopharmaceutical Chemistry and Applications 4
-
- Prostate Cancer Treatment and Research 5
- Prostate Cancer Diagnosis and Treatment 2
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
- Cancer, Lipids, and Metabolism 2
-
- Hormonal Regulation and Hypertension 3
-
- Adrenal and Paraganglionic Tumors 4
-
- Neuroblastoma Research and Treatments 1
Jessica Jensen
10 papers receiving 724 citations
Hit Papers
Peers
Comparison fields: 5 of 43
- Radiology, Nuclear Medicine and Imaging 336
- Pulmonary and Respiratory Medicine 471
- Cancer Research 186
- Endocrinology, Diabetes and Metabolism 109
- Oncology 119
Countries citing papers authored by Jessica Jensen
This map shows the geographic impact of Jessica Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Jensen more than expected).
Fields of papers citing papers by Jessica Jensen
This network shows the impact of papers produced by Jessica Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Jensen. The network helps show where Jessica Jensen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jessica Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Studybreakdown → | 2021 | 237 |
| 2 | 2021 | 2 | |
| 3 | A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)breakdown → | 2021 | 244 |
| 4 | An update on overall survival from a multi-center, open-label, pivotal phase 2b study of AZEDRA® (iobenguane I 131) in patients with iobenguane scan positive locally advanced or metastatic pheochromocytoma/paraganglioma (PPGL) | 2019 | 1 |
| 5 | 2019 | 1 | |
| 6 | 2019 | 1 | |
| 7 | Results from the OSPREY trial: A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients with PRostate Cancer - Examination of Diagnostic AccuracY | 2019 | 14 |
| 8 | 2018 | 191 | |
| 9 | 2017 | 42 | |
| 10 | 1976 | 2 |
About Jessica Jensen
Jessica Jensen is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 735 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Adrenal and Paraganglionic Tumors (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Hormonal Regulation and Hypertension (3 papers), Cancer, Lipids, and Metabolism (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (336 citations), Pulmonary and Respiratory Medicine (471 citations) and Cancer Research (186 citations). Jessica Jensen has collaborated with scholars based in United States and Canada. Frequent co-authors include Tess Lin, Vivien Wong, Nancy Stambler, Barry A. Siegel, Steven P. Rowe, Michael A. Gorin, Michael J. Morris, Frédéric Pouliot, Lawrence Saperstein and Peter R. Carroll. Their work appears in journals such as The Journal of Urology, Clinical Cancer Research, Journal of Nuclear Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.